Nano-structured Films for Ocular Drug Delivery

3/17/2021 14:05 - 14:40

Oculinea’s core technology developed at UCSF is a nano-engineered polymer thin film encapsulating drug payload in various configurations for ocular drug delivery of both small molecules and biologic therapeutics. The bio-resorbable drug delivery implant allows transport of drug molecules from a reservoir payload through a micro- and nano-structured porous polymer layer providing zero-order drug delivery for a few months to a year. This sustained drug delivery technology provides an ideal solution to address compliance issues with patient administered daily eye drops in treating chronic ocular conditions like glaucoma. The presentation will provide results from the progress made towards clinical translation of this novel technology.

Murty Vyakarnam, Co-founder & Chief Executive Officer , Oculinea Inc